SELLAS Life Sciences (SLS) Return on Equity (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Return on Equity for 9 consecutive years, with 3.43% as the latest value for Q3 2024.
- On a quarterly basis, Return on Equity rose 7343.0% to 3.43% in Q3 2024 year-over-year; TTM through Sep 2024 was 3.43%, a 7343.0% increase, with the full-year FY2023 number at 23.9%, up 2718.0% from a year prior.
- Return on Equity was 3.43% for Q3 2024 at SELLAS Life Sciences, up from 5.47% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 6.39% in Q4 2023 to a low of 76.86% in Q3 2023.
- A 5-year average of 8.01% and a median of 2.79% in 2022 define the central range for Return on Equity.
- Peak YoY movement for Return on Equity: plummeted -7407bps in 2023, then skyrocketed 7343bps in 2024.
- SELLAS Life Sciences' Return on Equity stood at 0.95% in 2020, then fell by -14bps to 1.08% in 2021, then crashed by -346bps to 4.81% in 2022, then skyrocketed by 233bps to 6.39% in 2023, then crashed by -154bps to 3.43% in 2024.
- Per Business Quant, the three most recent readings for SLS's Return on Equity are 3.43% (Q3 2024), 5.47% (Q2 2024), and 42.18% (Q1 2024).